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Medications in treatment and control of diabetes can be costly for pediatric 
patients and families.  Therefore, individuals may seek complementary and 
alternative therapies, such as cinnamon, in addition to traditional treatments.  
The objective of this study was to determine acceptability of using cinnamon in 
treatment of diabetes in a pediatric population with diabetes.  Seventy-six 
pediatric diabetes patients at a diabetes clinic participated in a one-time 
telephone interview using an 18-item, validated questionnaire.  Descriptive 
statistics were utilized to determine cinnamon acceptability and preferences.  The 
majority of the subjects were between 16-18 years (43%, n = 33), Caucasian 
(62%, n = 47), and female (67%, n = 51).  More than three-fourths were 
overweight or at risk of being overweight (80%, n = 60).  Seventy-six percent 
stated that they would be willing to try cinnamon for treatment of their diabetes, 
whereas 14.5% were undecided and 9.2% unwilling.  Most (n = 56, 52.5%) were 
willing to take the cinnamon supplement 1-2 times per day.  The greatest concerns 
expressed by subjects were side effects, interaction with current medications, and 
physician’s willingness to approve and prescribe.  This research suggests that in 
consultation with health professionals, diabetic youth are willing to try cinnamon 
supplementation in the treatment of diabetes.   
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Introduction  
 
According to a 2010 report from the Centers for Disease Control and Prevention (CDC, 2011), in 
the United States, about 215,000 people under age 20 have diabetes; this is 0.26% of individuals 
in this age group.  Each year from 2002-2005, 15,600 youth were newly diagnosed with type 1 
diabetes, and 3,600 were newly diagnosed with type 2 diabetes.  Diabetes is associated with 
higher risks of morbidity and mortality and is the 5th leading cause of death in America 
Direct correspondence to Valerie Amend at vaamend@bsu.edu Youth’s Acceptance of Cinnamon in Treating Diabetes                                                                          64 
Journal of Human Sciences and Extension      Volume 1, Number 2, 2013 
(American Association of Diabetes Educators, 2012).  Individuals with diabetes have two times 
the risk of death compared to individuals without diabetes (CDC, 2011).  Diabetes is associated 
with a number of complications that intensify with duration of the condition and is the leading 
cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness 
among adults (CDC, 2011).  Cardiovascular disease accounts for approximately 25% of deaths 
among patients with onset of diabetes before 20 years of age (American Association of Diabetes 
Educators, 2012).  Heart disease and stroke account for about 65% of deaths among all people 
with diabetes (American Association of Diabetes Educators, 2012).   
 
Individuals with diabetes aim to maintain proper control of their blood glucose and lipid levels to 
prevent related complications.  Methods to control these levels can include a controlled diet, 
exercise regimen, weight loss, oral medications, and/or insulin (CDC, 2011).  
 
Medications in treatment and control of diabetes can be costly, and their long-term safety is 
questionable (Eisenberg et al., 1993).  Therefore, individuals may seek complementary and 
alternative therapies such as use of spices and herbs (e.g., cinnamon, ginseng, davana, supari, 
and aloe vera) in addition to traditional treatments.  Several studies have examined the use of 
complementary and alternative medicine (CAM) in treatment of diabetes in adults (Broadhurst, 
Polansky, & Anderson, 2000; Egede, Ye, Zheng, & Silverstein, 2002; Garrow & Egede, 2006; 
Jarvill-Taylor, Anderson, & Graves, 2001; Khan, Bryden, Polansky & Anderson, 1990; Khan & 
Safdar, 2003; Ryan, Pick, & Marceau, 2001; Schoenberg, Stoller, Kart, Perzynski, & Chapleski, 
2004; Shapiro & Gong, 2002; Yeh, Eisenberg, Davis, & Phillips, 2002; Yeh, Eisenberg, 
Kaptchuk, & Phillips, 2003).   
 
Recently, more studies have focused on cinnamon supplementation, specifically in adult 
diabetics (for example Crawford, 2009; Klein et al., 2005; Magistrelli & Chezem, 2012; Vafa et 
al., 2012), with varying results.  While an analysis of ten prospective, parallel-group design, 
randomized controlled trials on cinnamon and diabetes by Leach and Kumar (2012) found there 
was not sufficient evidence to support the use of cinnamon for type 1 or 2 diabetes, studies by 
Hlebowicz, Darwiche, Björgell, and Almér (2007) and Magistrelli and Chezem (2012) suggest 
cinnamon may be effective in moderating postprandial glucose response in normal weight and 
obese adults.  Altschuler, Casella, MacKenzie, and Curtis (2007) found the use of cinnamon does 
not produce significant improvements in Hemoglobin A1c (HbA1c) for type 1 diabetes, as the 
disease has different pathophysiology than type 2 diabetes.  Still, the number of type 2 diabetes 
diagnoses in populations under the age of 20 has climbed.  To date, little research has examined 
the efficacy of using cinnamon with the pediatric population or the willingness of diabetic youth 
to use cinnamon for treatment of diabetes.  Therefore, the purpose of this descriptive pilot study 
was to determine youth’s preference and acceptability of cinnamon as a complementary therapy 
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Materials and Methods 
 
One-hundred and seventy-seven pediatric patients who attend or have previously attended a 
diabetes clinic at a large Midwestern children’s hospital were invited to participate in the study.  
Names and contact information of the participants were obtained from the clinic’s pediatric 
endocrinologist.  Subjects’ inclusion criteria for the study included the following: 1) age 10-18 
and 2) diagnosed with either type 1 or type 2 diabetes for over 1 year.  Patients who were 
pregnant were excluded from this study.  Prior to data collection, parental-patient consent was 
obtained for release of all pertinent medical information. 
 
An 18-item telephone interview questionnaire (12 questions related to cinnamon use and 
diabetes; 6 demographic questions) was used as a script.  The interview questions were reviewed 
by one endocrinologist, two pediatric dietitians, and two parents for face validity to ensure 
appropriateness for the pediatric population.  Reliability was not assessed because the interview 
questionnaire was simply measuring conditions and opinions of youth diabetic patients via 
telephone; actual use of cinnamon was not assessed.  Upon approval of the study protocol from 
the Institutional Review Board, a one-time telephone interview was conducted using the 
questionnaire.  A single researcher conducted all interviews to ensure uniformity in questions.  
Heights and weights were retrieved from subject’s most recent medical records.  Descriptive 
statistics were computed using SPSS software.  Further statistical analysis was not utilized due to 
the preliminary nature of the study and relatively small sample size.  Also, researchers were not 
looking at effectiveness of cinnamon, rather acceptance with the population described.  
 
Results 
 
From a pool of 177 pediatric diabetic patients, 76 successfully completed the research.  Of the 
remaining 101 potential subjects, 97 could not be contacted due to disconnection of telephone 
services, incorrect numbers, and/or lack of telephone accessibility.  Two patients were over 18 
years of age, and two denied having diabetes.  
 
As shown in Table 1, 67% (n = 51) were female, and 33% (n = 25) were male.  A majority of 
subjects were age 16-18 years (43%, n = 33) and Caucasian (62%, n = 47).  Other ethnicities 
represented were African American (n = 25), Asian (n = 2), Latino (n = 1), or mixed (n = 1).  
Calculation of Body Mass Index for Age indicated 20% of children (n = 15) were at a healthy 
weight, 25.3% (n = 19) were at risk for overweight, and 54.7% (n = 41) were overweight. 
 
Table 2 presents descriptive statistics related to the current health regimen of participants, 
including type of diabetes, special diets used, and types and frequency of medications used to 
control diabetes.  The most commonly used types of insulin were Novolog (n = 24, 31.6%) and 
Lantus (n = 16, 21.1%).  Metformin was the most used oral medication (n = 51, 67.1%).  Youth’s Acceptance of Cinnamon in Treating Diabetes                                                                          66 
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Table 1.  Demographic Information of Subjects (N = 76) 
  n (%) 
Gender   
Female  51 (67.1) 
Male  25 (32.9) 
Age   
10-12  16 (21.1) 
13-15  27 (35.5) 
16-18  33 (43.4) 
Ethnicity   
African American  25 (32.9) 
Asian  2 (2.6) 
Latino  1 (1.3) 
Mixed  1 (1.3) 
Caucasian  47 (61.8) 
 
 
          Table 2.  Current Health Regimen of Participants (N = 76) 
  n (%) 
Type of Diabetes   
Type 1  24 (31.6) 
Type 2  52 (68.4) 
Type of Diet Used   
1500-1800 ADA  2 (2.6)  
Carbohydrate Counting  23 (30.3) 
Eat Less Food  6 (7.9)  
Eat Less Sweets  3 (3.9)  
Limit Carbohydrates  2 (2.6) 
Low Carb/Low Fat  1 (1.3) 
No Regular Soda  1 (1.3) 
Type Not Provided                             2 (2.6)  
No Special Diet Used  36 (47.3) 
Type of Medication   
Actose  5 (6.6) 
Amaryl  2 (2.6) 
Byetta  1 (1.3) 
Humalog/Humulin  16 (21.1) 
Lantus  16 (21.1) 
Lente    2 (2.6) 
Levamir  1 (1.3) 
Metformin  51 (67.1) 
Novolog  24 (31.6) 
NPH  5 (6.6) 
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Over three-fourths of youth (76.3%, n = 58) stated that they would be willing to try cinnamon for 
treatment of their diabetes, whereas 14.5% (n = 11) were undecided, and 9.2% (n = 7) were 
unwilling to try (see Table 3).  When questioned on their preference for the type of supplement 
(e.g., pill, liquid, either) and frequency of use, the majority of those who were willing to try 
cinnamon or were undecided stated they would prefer a pill.  Interestingly, more than 30% 
(34.2%, n = 26) were willing to try either the pill or liquid form of the supplement.  More than 
50% (60.5%, n = 46) were willing to take the cinnamon supplement 1-2 times per day.  A small 
proportion (2.6%, n = 2) expressed a desire to take it an unlimited number of times daily.  When 
asked if cinnamon could help control blood glucose levels, the majority of youth were 
undecided, while a little over one-third stated yes.  
 
    Table 3.  Participants’ Supplement Preferences (N = 76) 
  n (%) 
Willing to Try Cinnamon   
Yes  58 (76.3) 
No  7 (9.2) 
Undecided  11 (14.5) 
Supplement Form   
Pill  30 (39.5) 
Liquid  13 (17.1) 
Either  26 (34.2) 
Neither  7 (9.2) 
Times per Day   
0  7 (9.2) 
1  18 (23.7) 
2  28 (36.8) 
3  14 (18.4) 
4  5 (6.6) 
5  1 (1.3) 
6  1 (1.3) 
Unlimited  2 (2.6)  
 
In response to diabetic adolescents, concerns regarding the use of cinnamon, the greatest 
concerns were side effects (72.4%, n = 55) and interaction with current medications (64.5%,  
n = 49).  The least concern was number of times the cinnamon supplement would have to be 
taken each day.  Other concerns reported by participants that may influence consideration of 
cinnamon supplement included: 1) the effect on physiological bodily functions (e.g., eyesight, 
organs, weight, and nerve impairment) and medical conditions (e.g., asthma, allergies, and 
dermatological issues); 2) palatability (e.g., taste alteration); 3) effectiveness of supplement; and 
4) physicians’ willingness to approve and prescribe (see Table 4).  
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Table 4.  Potential Concerns Expressed by Participants  
Regarding Cinnamon Supplement Use (N = 76) 
        n (%) 
Side Effects   
Yes  55 (72.4) 
No  21 (27.6) 
Cost   
Yes  45 (59.2) 
No  31 (40.8) 
Insurance Coverage   
Yes  39 (51.3) 
No  37 (48.7) 
Number of Times Taken Per Day   
Yes  29 (38.2) 
No  47 (61.8) 
Interaction with Current Medications   
Yes  49 (64.5) 
No  27 (35.5) 
Other   
Yes  8 (10.5) 
No  68 (89.5) 
 
Discussion 
 
Limited investigations have been conducted regarding diabetic youth’s acceptability of cinnamon 
as treatment for diabetes.  However, several studies have looked at complementary and 
alternative (CAM) medicine use and the effectiveness of cinnamon.  Research by Low, Murray, 
O’Mahony, and O’B Hourihane (2008) looked at the prevalence of CAM use among the 
pediatric population in Ireland.  Questionnaires were distributed over 4 months to 13 pediatric 
settings.  Researchers found 57% of parents reported using CAM for their child, with the highest 
usage reported in 2-4 year olds.  A similar study conducted in 2010 by Birdee, Phillips, Davis, 
and Gardiner examined factors associated with pediatric use of CAM in the United States.  They 
found pediatric CAM users (n = 9,417) were more likely to be adolescents (AOR 1.36 [1.02-
1.80], to have a parent who used some form of CAM (AOR 3.83 [3.04-4.84], and more likely to 
take prescription medications (AOR 1.51 [1.19-1.92]).  A Finnish study by Hämeen-Anttila, 
Niskala, Siponen, and Ahonen (2011) examined the use of CAM among the parents of children 
under the age of 12 to determine parents’ influence on the children’s future use.  The study 
examined 4,032 surveys.  Thirty-one percent of subjects reported using some type of CAM in the 
preceding two days.  Researchers concluded that women over 30 years of age, with higher 
education and higher incomes, were more likely to use CAM.   
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Research most similar to the present study was conducted in 2005 by Klein et al. (2005) and 
explored adolescents’ knowledge of and beliefs about dietary supplements, herbs, and over-the-
counter medications.  Subjects included 81 adolescents from various groups: suburban 
adolescents, urban minority adolescents, adolescents with chronic illness (including diabetes), 
and patients of complementary and alternative medicine practitioners.  Focus group results 
indicated that most adolescents understood the terms “herbal medicine,” “herbal remedies,” or 
“nutritional supplements,” but many were unfamiliar with the term “alternative medicine.”  In 
addition, most adolescents were familiar with CAM therapies used by people from their own 
culture, and most linked use of CAM for treatment of illness rather than preventative care.  
 
The effectiveness of cinnamon as an alternative or adjunctive therapy for blood glucose control 
in the adult population has been studied in recent years, with varying results.  Crawford (2009) 
utilized a randomized controlled trial to determine the effectiveness of cinnamon in lowering 
Hemoglobin A1c (HbA1c) levels in 109 patients with type 2 diabetes.  The control group 
received usual medical care, while the experimental group received medical care in addition to 
cinnamon capsules.  Results indicated HbA1c levels in the experimental group were lowered by 
0.83% (95% CI, 0.4601.2) compared to usual care lowering of HbA1c by 0.37% (95% CI, 0.15-
0.59).  Vafa et al. (2012) examined the effects of cinnamon consumption on glycemic status of 
44 patients with type 2 diabetes in a double-blind placebo-controlled study.  They found no 
significant differences in glycemic indicators between the placebo and treatment groups.  
Research conducted by Hlebowicz et al.  (2007) investigated the effect of cinnamon on 
postprandial glucose in 14 healthy subjects using a crossover trial.  Results indicated the addition 
of 6 grams of cinnamon to a meal lowered the postprandial glucose response (p < 0.05).  The 
recent study from Magistrelli and Chezem (2012) found the addition of 6 grams of cinnamon to 
the cereal significantly reduced 120-minute glucose AUC (p=0.008) and blood glucose at 15 (p = 
0.001), 30 (p < 0.001), 45 (p < 0.001), and 60 (p = 0.001) minutes.  At 120 minutes, blood 
glucose was significantly higher with cinnamon consumption (p < 0.001) compared to a control 
group.  
 
The present study was unique for several reasons: 1) diabetic youths’ perceptions on cinnamon 
use was gathered using telephone interviews; 2) it is one of the few to examine the pediatric 
diabetic population’s acceptance of cinnamon in regulation of blood glucose levels; and 3) in 
addition to information on current usage, this research obtained detailed information on mode of 
administration (including form and frequency) and potential concerns reported by diabetic youth 
with the use of cinnamon as CAM.  There were limitations to this pilot study, including the 
sample selection which was confined to diabetic children and adolescents at one hospital with 
telephone accessibility.  The use of a closed-ended questionnaire could lead to bias, and parents 
may have influenced the participants and possibly their answers to interview questions.  Future 
research could focus on a qualitative inquiry to further explore the results of the present study, 
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The rise in diabetes in the pediatric population has encouraged health professionals to examine 
alternative forms of treatment.  When compared to conventional therapies, it is possible that 
utilization of cinnamon may be beneficial in diabetes control resulting in greater patient 
compliance with decreased side effects.  While it is premature to recommend cinnamon as a 
treatment for pediatric diabetes based on lack of research with this population, this preliminary 
study suggests that in consultation with health professionals, diabetic youth are willing to try 
cinnamon in the form of a pill as an alternative (or in conjunction with traditional medical care) 
in the treatment of diabetes.  
 
Diabetes management is a collaborative effort and alternative treatments add another avenue to 
address the growing issue of pediatric diabetes.  Barriers may be addressed by working with 
community organizations, hospitals and schools to disperse information on new treatments as 
they become available.  Should research continue to support improved outcomes with the use of 
cinnamon for blood glucose control in type 2 diabetes, it is important to know if prospective 
patients would be open to utilizing new methods of treatment.  The findings of the present study 
reveal that the majority would be open to trying cinnamon if it is proven a reliable treatment.  
Therefore, randomized clinical trials with this population would be recommended to determine 
the efficacy of using cinnamon as a complementary treatment for diabetes.  
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